We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+16.4%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17.2B
AUM Growth
+$2.48B
(+17%)
Cap. Flow
+$325M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
22.01%
Holding
269
New
35
Increased
117
Reduced
69
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$122M |
| 2 |
Ross Stores
ROST
|
+$91.9M |
| 3 |
Comfort Systems
FIX
|
+$78.8M |
| 4 |
Microsoft
MSFT
|
+$76.7M |
| 5 |
McDonald's
MCD
|
+$65.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$142M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$136M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$97.8M |
| 4 |
Visteon
VC
|
+$91.7M |
| 5 |
Diageo
DEO
|
+$73.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.89% |
| 2 | Healthcare | 18.74% |
| 3 | Industrials | 16.41% |
| 4 | Consumer Discretionary | 12.58% |
| 5 | Financials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CRISPR Therapeutics
CRSP
$5.17B
| – | – |
-297,550
| Closed | -$13.5M |
|
|
252
Diageo
DEO
$53.6B
| – | – |
-495,284
| Closed | -$73.9M |
|
253
Domo
DOMO
$184M
| – | – |
-167,758
| Closed | -$1.65M |
|
254
Essex Property Trust
ESS
$18.5B
| – | – |
-149,886
| Closed | -$31.8M |
|
255
Floor & Decor
FND
$6.68B
| – | – |
-4,500
| Closed | -$407K |
|
|
256
Fortinet
FTNT
$117B
| – | – |
-2,412,418
| Closed | -$142M |
|
257
Humana
HUM
$46.2B
| – | – |
-482
| Closed | -$235K |
|
258
Lyft
LYFT
$6.63B
| – | – |
-26,350
| Closed | -$278K |
|
259
Nike
NKE
$61.9B
| – | – |
-72,376
| Closed | -$6.92M |
|
260
NET Power
NPWR
$134M
| – | – |
-21,880
| Closed | -$330K |
|
261
NetApp
NTAP
$37.2B
| – | – |
-533,589
| Closed | -$40.5M |
|
262
PepsiCo
PEP
$190B
| – | – |
-54,876
| Closed | -$9.3M |
|
|
263
Sarepta Therapeutics
SRPT
$1.77B
| – | – |
-806,400
| Closed | -$97.8M |
|
264
StepStone Group
STEP
$3.82B
| – | – |
-913,069
| Closed | -$28.8M |
|
265
Bio-Techne
TECH
$11.3B
| – | – |
-699,662
| Closed | -$47.6M |
|
|
266
Visteon
VC
$2.78B
| – | – |
-664,137
| Closed | -$91.7M |
|
|
WCC
267
WESCO International
WCC
$17.7B
| – | – |
-117,245
| Closed | -$16.9M |
|
|
SPLK
268
DELISTED
Splunk Inc
SPLK
| – | – |
-929,975
| Closed | -$136M |
|
|
MDRX
269
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-2,401,754
| Closed | -$31.6M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Westfield Capital Management held 269 positions worth $17.2B, up 17% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Westfield Capital Management's Q4 2023 filing shows 35 new, 117 increased, 69 reduced and 30 closed positions. Its largest new stake was AbbVie: 839,739 shares worth $130M. The largest sale was Fortinet, an estimated $142M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2023 buy was AbbVie: 839,739 shares worth $130M.
- Westfield Capital Management added most to Microsoft in Q4 2023, an estimated $76.7M increase.
- Westfield Capital Management's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $68.7M.
- Westfield Capital Management fully exited Fortinet in Q4 2023, selling an estimated $142M.
- Westfield Capital Management's ten largest holdings make up 22% of its $17.2B portfolio in Q4 2023.
- Westfield Capital Management opened 35 new positions and closed 30 in Q4 2023.
- Westfield Capital Management's portfolio value rose 17% quarter-over-quarter to $17.2B.
Based on Westfield Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.